XYNOMIC PHARMACEUTICALS HOLDINGS, INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $6.35 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-06-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2020-06-01
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2019-12-31 was $1.19M, a 90.70% decline year-over-year.
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2019-09-30 was $3.66M.
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2018-12-31 was $12.76M.
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2018-09-30 was -$1.26M.
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2019 was $6.35M, a 54.91% decline from fiscal 2018.
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2018 was $14.07M.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2019-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-01 | $4.85M derived: sum of 2 quarters · filed 2020-06-01 | $6.35M 10-K · filed 2020-06-01 | |
| 2019-09-30 | $3.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $5.16M 10-Q · filed 2019-11-14 | ||
| 2019-06-30 | $1.50M 10-Q · filed 2019-08-15 | |||
| 2018-12-31 | $12.76M derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-01 | $11.49M derived: sum of 2 quarters · filed 2020-06-01 | $14.07M 10-K · filed 2020-06-01 | |
| 2018-09-30 | -$1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $1.32M 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | $2.58M 10-Q · filed 2019-08-15 |